RemoteRx, created by Real Time Touch, is a telemedicine platform that contains remote medication release dispensers for better monitoring of prescribed drugs, and is paired with IoT hardware and sensor capabilities. Real Time Touch has released four videos highlighting how their technology can impact a variety of healthcare factors, such as providing seniors with more independence, reducing readmissions, and more.
A Little Help for Seniors
When seniors forget to take vital daily medications, it can be a worrisome sign for caregivers and doctors. Often, they may consider relocating seniors to an assisted living home for constant monitoring. With the RemoteRx technology, seniors could visit with caregivers who would remotely release their scheduled medications, monitor their vitals, and access their health status during virtual visits. Real Time Touch envisions their platform being integrated into existing virtual health systems with 24/7 monitoring. This could connect the healthcare process for everyone including the patient, pharmaceutical and insurance companies, and healthcare professionals.
Once a patient is released after their hospital stay, they often require follow-ups and frequent doctor or caregiver attention. A solution being developed by Real Time Touch is the remote release of critical medications during virtual nurse-to-patient interactions to help enable at-home recovery. This could reduce the daily or weekly outings to the doctor’s office, and give caregivers the ability to monitor vital signs remotely while verifying if the correct medication was taken at the right time.
Addressing Opioid Dependence
Drugs are an effective and important part of recovery, but they also come with the chance of overuse and dependence. Real Time Touch believes its platform and remote controlled treatment could help monitor an individual’s medication intake. Real Time Touch envisions the Remote Rx design to include caregiver alerts, AI coaching, voice activation, gesture recognition, biomarkers, AR, and more.
They also foresee that test medications could be released by a clinical trial clinician and pair with video conferencing to assess a patient in their own home. The clinical trial scenarios and medication adherence would be monitored in real time, and be combined with vitals data for faster scientific research and better monitoring. If approved by the FDA, the clinical trial patients’ test medications would be released remotely, verified, and recorded via an at-home, IoT locked dispenser. This would only be available while the clinician or AI assistant was virtually present.
Currently, Real Time Touch is working with partners to assist with the development of this platform and obtain FDA approval pertaining to the healthcare cases in the videos above.